Celldex Therapeutics, Inc. Operating Loss Carryforwards
Celldex Therapeutics, Inc. (CLDX) had Operating Loss Carryforwards of $17.70 million as of 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2017-03-14
- 2016-12-31: Operating Loss Carryforwards $17.70M.
- 2015-12-31: Operating Loss Carryforwards $17.70M.
- 2014-12-31: Operating Loss Carryforwards $8.00M.
- 2013-12-31: Operating Loss Carryforwards $6.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2016-12-31 | $17.70M 10-K · filed 2017-03-14 |
| 2015-12-31 | $17.70M 10-K/A · filed 2016-02-25 |
| 2014-12-31 | $8.00M 10-K · filed 2015-02-24 |
| 2013-12-31 | $6.00M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |